viewFeedback PLC

Feedback lands first contract from its tie-up with imaging giant GE Healthcare

Feedback business development director, Dr Balaji Ganeshan, called the deal an “important milestone”

medical image screens
The end user will be the Post Graduate Institute of Medical Education & Research, Chandigarh, India

Shares in Feedback plc (LON:FDBK) shot up 17% on Wednesday on news it had received its first order from GE Healthcare for TexRAD, its image texture technology.

The contract is the first from a distribution agreement signed in April with the American diagnostics giant.

READ: Feedback’s new boss sets out his stall after strategic review

The end user will be the Post Graduate Institute of Medical Education & Research, Chandigarh, India. 

Feedback business development director, Dr Balaji Ganeshan, called the deal an “important milestone”.

“That one of India's leading medical institutions has selected TexRAD against other image analysis candidates is a strong endorsement of our technology," he added.

TexRAD was the brainchild of Ganeshan, an expert on textural analysis of images gleaned from computed tomography (CT) scans.

Smart piece of software

Distilled down to the basics, it is essentially a very smart piece of software that analyses medical images to reveal features that are not always evident to the human eye.

In doing so, it may “in a very statistical, objective and numerical way relate the output to a prognosis for the patient”, chairman Dr Alastair Riddell told Proactive recently.

Feedback is already making money from TexRAD with sales to institutions carrying out research, but the promised land is filled with sales to hospitals.

Feedback Medical Limited has self-certified TexRAD Lung as a Class I Medical Device, in compliance with the requirements of the EU Medical Device Directive, meaning TexRAD Lung is a Medical Device CE marked for use in the EU. This will enable Feedback to lend numerical support to the very skilled, interpretative work carried out by radiologists.

Meanwhile, a tie-up with a company in Poland called Future Processing provides Feedback with the coding know-how to develop a wider product suite.

Demand for product

Sales of the current product, though modest, reveal there is demand from a very specialist audience in the research sphere.

It means the technology is being cited in the literature by some of the leading centres for cancer research – providing a great endorsement of the TexRAD from key opinion leaders.

In fact, the technology is also starting to make an impression with businesses operating in the field.

The stock advanced 0.3p to 2.10p.

---Adds background---


Quick facts: Feedback PLC

Price: 0.96 GBX

Market: LSE
Market Cap: £10.24 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Feedback PLC named herein, including the promotion by the Company of Feedback PLC in any Content on the Site, the Company receives from said...



Feedback's Tom Oakley discusses plans for Bleepa rollout following £5.5mln raise

Feedback's (LON:FDBK) Tom Oakley speaks to Proactive London's Andrew Scott following the news they've raised £5.05mln through a placing plus they're looking to bring in an additional £540k through an open offer to existing shareholders. He says the cash will be used to develop their flagship...

4 weeks ago

2 min read